ࡱ> b  !"BC$%&'()*+,-./0123456789:;<=>?@ADFEGaIJKLMNOPQRSUVWXYZ[\]^_`defghijklmnopqrstuvwxyz{|}~Root Entry? FЎQϧ__nameid_version1.0( 0(ϧ,,ϧ__substg1.0_00020102*p__substg1.0_00030102*X *-.14589<>BFGHKLMOVW[`bcilopuvw{}Pc ̜_ FAAZk 3z.B{yᩎT##]h2GULN3k?@0GZ+F0 d    x    < x  h( \   4  <l !l"#$P% & ' (H ) * + , - . /P 0 1 2 3p 4 5 6p 7 89D:;<( =d>?@ A\B|C DE F8GT HIJۚE ͼ^3%:C Da) (/6;34% Ap + 槥 u%*C__substg1.0_00040102*__substg1.0_10000102* __substg1.0_10010102* __substg1.0_10020102*,BigFunnelCorrelationId0ExchangeApplicationFlagsHasQuotedText&IsQuotedTextChanged.LastIndexingAttemptTime,HeaderBodyFragmentList^X-MS-Exchange-Organization-ATPSafeLinks-MsgData2CurrentMessageSafetyFlags NetworkMessageId$IsPartiallyIndexed<BigFunnelCompleteIndexingStart8BigFunnelCompleteIndexingEnd DetectedLanguage6ConversationIndexTrackingEx>OriginalInferenceClassificationHGriffinInferenceClassificationResult:InferenceClassificationResultBGriffinTriageHeuristicsFeatureSet4TriageHeuristicsFeatureSet.EntityExtraction/Url1.0>EntityExtraction/EmbeddedUrl1.0,ClassificationLastScan,LatestMessageWordCountIsSignedIsReadReceiptJX-Microsoft-Antispam-Mailbox-DeliveryBX-Microsoft-Antispam-Message-Info4InferenceMessageIdentifier2ConversationContributions,ConversationWasFocusedJx-ms-exchange-organization-authsourceBx-ms-exchange-organization-authasdx-ms-exchange-organization-originalclientipaddressdx-ms-exchange-organization-originalserveripaddress,x-ms-publictraffictypeFDetailedClassificationSchemeEnabled.ClassificationContextV2 IsExternalSenderFEntityExtraction/ExtractLanguage1.0NEntityExtraction/KeyPhraseExtraction2.0:InferenceClassificationReasonBInferenceClassificationTrackingEx,FocusedInboxModelScorereceived-spfrX-MS-Exchange-Organization-ATPSafeLinks-UrlContainer-Data|X-MS-Exchange-Organization-ATPSafeLinks-UrlContainer-Signature6x-forefront-antispam-report,authentication-results4x-ms-traffictypediagnosticZx-ms-exchange-crosstenant-originalarrivaltimeTx-ms-exchange-crosstenant-fromentityheader8x-ms-exchange-crosstenant-idbx-ms-exchange-transport-crosstenantheadersstampedXx-ms-exchange-crosstenant-network-message-idNx-ms-exchange-transport-endtoendlatencyNx-ms-office365-filtering-correlation-id(x-microsoft-antispamNx-ms-exchange-processed-by-bccfolderingHx-ms-exchange-crosstenant-authsource@x-ms-exchange-crosstenant-authas8AntispamSafeLinksWrappedUrlsDx-ms-exchange-atpmessageproperties,x-eopattributedmessage8x-eoptenantattributedmessage@AntispamSafelinksIsIntraOrgEmailBodyLanguages&AttachmentLanguagesDX-MS-Exchange-Organization-BUABFLCIsNotToMe,EntityExtraction/IsM2HFIFeatureSetVEntityExtraction/KPEM2HItemProcessorSuccess__substg1.0_10030102* __substg1.0_10040102*__substg1.0_10050102*__substg1.0_10060102* X HE, .=D\E! - D6C2h*(l$,B &?GS buT a F__substg1.0_10070102*__substg1.0_10080102* __substg1.0_10090102*__substg1.0_100C0102*__substg1.0_100D0102*__substg1.0_100F0102* __substg1.0_10100102*__substg1.0_10110102* /l#Z,"#Դ5j 5 d7%h (jB  uK V#j09 -?lQK9zih< b@F  d ߻c8 Q I__substg1.0_10120102* __substg1.0_10130102*(__substg1.0_10140102*__substg1.0_10150102*__substg1.0_10160102*__substg1.0_10170102* __substg1.0_10180102*!__substg1.0_10190102*"b. ?J V D&ә~b1xjDڱ+?G ™4 yz  ''u%+}=2I y6)v =N>V!P7__substg1.0_101A0102*#__substg1.0_101B0102*$ __substg1.0_101C0102*%__substg1.0_101D0102* &__substg1.0_101E0102*'__substg1.0_001A001F*"(__substg1.0_0037001F*)~__substg1.0_003B0102*!%+IPM.NoteIRAS Project ID 316755. HRA and HCRW Approval for the AmendmentSMTP:NOREPLY@HARP.ORG.UKܧ@B+//O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SISSIS, Resource__substg1.0_003D001F*__substg1.0_003F0102*$&,__substg1.0_0040001F*/__substg1.0_00410102*#+0v+nTamendments@hra.nhs.ukSMTPnoreply@harp.org.ukamendments@hra.nhs.ukܧ@B+//O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SISSIS, Resource~z+nTamendments@hra__substg1.0_0042001F*2*__substg1.0_00430102*(*3__substg1.0_0044001F*6__substg1.0_004F0102*)-7.nhs.ukSMTPamendments@hra.nhs.ukamendments@hra.nhs.ukEX:/O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SISEX:/O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SISSMTP__substg1.0_0050001F*:*__substg1.0_00510102*,.;|__substg1.0_00520102*=|__substg1.0_0064001F*'7?__substg1.0_0065001F*@&__substg1.0_0070001F*02A~__substg1.0_00710102*C__substg1.0_0075001F*15Dnoreply@harp.org.ukIRAS Project ID 316755. HRA and HCRW Approval for the AmendmentۧI/-JeP dEX/O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F__substg1.0_0076001F*E__substg1.0_0077001F*46I__substg1.0_0078001F*J__substg1.0_007D001F*3;# =495C875F5632DDE22D7C-SISEX/O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SIS+nTamendments@hra.nhs.ukSMTPnoreply@harp.org.ukReceived: from DU0PR01MB9358.eurprd01.prod.exchangelabs.com (2603:10a6:10:35e::10) by DB7PR01MB4396.eurprd01.prod.exchangelabs.com with HTTPS; Mon, 7 Apr 2025 15:03:57 +0000 Received: from DB9PR05CA0007.eurprd05.prod.outlook.com (2603:10a6:10:1da::12) by DU0PR01MB9358.eurprd01.prod.exchangelabs.com (2603:10a6:10:35e::10) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.8606.32; Mon, 7 Apr 2025 15:03:56 +0000 Received: from DU6PEPF0000B61F.eurprd02.prod.outlook.com (2603:10a6:10:1da:cafe::e3) by DB9PR05CA0007.outlook.office365.com (2603:10a6:10:1da::12) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.20.8606.34 via Frontend Transport; Mon, 7 Apr 2025 15:03:55 +0000 Authentication-Results: spf=pass (sender IP is 5.101.140.163) smtp.mailfrom=harp.org.uk; dkim=none (message not signed) header.d=none;dmarc=bestguesspass action=none header.from=harp.org.uk;compauth=pass reason=109 Received-SPF: Pass (protection.outlook.com: domain of harp.org.uk designates 5.101.140.163 as permitted sender) receiver=protection.outlook.com; client-ip=5.101.140.163; helo=cpanel.harp.org.uk; pr=C Received: from cpanel.harp.org.uk (5.101.140.163) by DU6PEPF0000B61F.mail.protection.outlook.com (10.167.8.134) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.8632.13 via Frontend Transport; Mon, 7 Apr 2025 15:03:55 +0000 Received: from [178.22.160.68] (port=52675 helo=HRA-HARPAPP02) by cpanel.harp.org.uk with esmtpa (Exim 4.98.1) (envelope-from <noreply@harp.org.uk>) id 1u1o0y-000000007Iz-0cgr; Mon, 07 Apr 2025 16:03:55 +0100 MIME-Version: 1.0 From: "amendments@hra.nhs.uk" <noreply@harp.org.uk> To: mark.wilson19@nhs.net, k.boland@imperial.ac.uk Cc: sis@warwick.ac.uk Reply-To: amendments@hra.nhs.uk Date: 7 Apr 2025 16:03:54 +0100 Subject: IRAS Project ID 316755. HRA and HCRW Approval for the Amendment Content-Type: text/html; charset=utf-8 Content-Transfer-Encoding: base64 X-AntiAbuse: This header was added to track abuse, please include it with any abuse report X-AntiAbuse: Primary Hostname - cpanel.harp.org.uk X-AntiAbuse: Original Domain - warwick.ac.uk X-AntiAbuse: Originator/Caller UID/GID - [47 12] / [47 12] X-AntiAbuse: Sender Address Domain - harp.org.uk X-Get-Message-Sender-Via: cpanel.harp.org.uk: authenticated_id: noreply@harp.org.uk X-Authenticated-Sender: cpanel.harp.org.uk: noreply@harp.org.uk X-Source: X-Source-Args: X-Source-Dir: Message-ID: <a1867882-2b05-4a13-8761-51bdad89cf93@DU6PEPF0000B61F.eurprd02.prod.outlook.com> Return-Path: noreply@harp.org.uk X-MS-Exchange-Organization-ExpirationStartTime: 07 Apr 2025 15:03:55.7377 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: 5afeb06e-035a-4259-109c-08dd75e56ade X-EOPAttributedMessage: 0 X-EOPTenantAttributedMessage: 09bacfbd-47ef-4465-9265-3546f2eaf6bc:0 X-MS-Exchange-Organization-MessageDirectionality: Incoming X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: DU6PEPF0000B61F:EE_|DU0PR01MB9358:EE_|DB7PR01MB4396:EE_ X-MS-Exchange-Organization-AuthSource: DU6PEPF0000B61F.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Office365-Filtering-Correlation-Id: 5afeb06e-035a-4259-109c-08dd75e56ade X-MS-Exchange-AtpMessageProperties: SA|SL X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:2;ARA:13230040|3072899012|12012899012|2092899012|8096899003|13003099007|43540500003; X-Forefront-Antispam-Report: CIP:5.101.140.163;CTRY:GB;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:cpanel.harp.org.uk;PTR:cpanel.harp.org.uk;CAT:NONE;SFTY:9.25;SFS:(13230040)(3072899012)(12012899012)(2092899012)(8096899003)(13003099007)(43540500003);DIR:INB;SFTY:9.25; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 07 Apr 2025 15:03:55.6595 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 5afeb06e-035a-4259-109c-08dd75e56ade X-MS-Exchange-CrossTenant-Id: 09bacfbd-47ef-4465-9265-3546f2eaf6bc X-MS-Exchange-CrossTenant-AuthSource: DU6PEPF0000B61F.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Anonymous X-MS-Exchange-CrossTenant-FromEntityHeader: Internet X-MS-Exchange-Transport-CrossTenantHeadersStamped: DU0PR01MB9358 X-MS-Exchange-Transport-EndToEndLatency: 00:00:01.9298160 X-MS-Exchange-Processed-By-BccFoldering: 15.20.8583.043 X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(4710137)(4713057)(470014026)(4714077)(4999040)(920097)(930097)(140003)(1420198); X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?0maCAkKjodYjFt6jeH53Rw7tFK3J0cvHoWe66As0bacz+uJrzt8Pbe/RTEK8?= =?us-ascii?Q?Wl/jMfIzVG3obnp30E9kzwjAqJRs1qABi5MmjJGtrgZeed6D0Z4uKX17ydCC?= =?us-ascii?Q?q6XWDntkswfVNJqVY5cRnnbkCo3F1bYsrjrVe20ZJkgIlUpy1A7tJO2DutTt?= =?us-ascii?Q?2n9HZxAfV1+Qg6EWBIsEJWImRKa7oXGxw4NywqBWYa8IndcBujgKah0IrEhI?= =?us-ascii?Q?ggAyN0OwMzITlFZQuwweAJDayY+RdBla5/i4SLoUc5JhPoYPloDNcHnbkj21?= =?us-ascii?Q?eGp7Qpgg0++7jR6JHa1GH22xoRHHuOizYEnoTQcr21BnibQTZQWb1hpHKuKU?= =?us-ascii?Q?yLnE4S0RNASVyASou9oaLn2Jjos16NUPFW56Lb5FAwMLVYFLNEb4gd77brNY?= =?us-ascii?Q?vWdMKtjI4qQ+m8R8WW7YV3vw2KeabIHWZje2SDaOu8XSWMsUEGfxVQ/20H7e?= =?us-ascii?Q?xls2P7nJIUgboTPyxeUrc/Bpa6VIcFmrF4z8sOe/oknir/btD/Tj0E1TDJ7V?= =?us-ascii?Q?enM5XHoTF3EL6Vwlqqg5DKU7Vg2t1RNrEYUOyxC48LJKS2U/DA9We6EjBiRr?= =?us-ascii?Q?DsW41JX3Lc+R3deDQEKgR8TGnUg1WRbu7+hR7A0E9v5/hSRBHYHw9bL+67A0?= =?us-ascii?Q?DdZGTTVqtbEc07+dE/WVs5VDqwENTPfo8Gie1BhHHs2e6gZJUlP7ISobHnWk?= =?us-ascii?Q?enf5qPOz+ImPTyHHtfqrouXnnt/Q63Soy7hI514qkeIixfserx61xZlEUwyu?= =?us-ascii?Q?cI0LE19HfEXsK+VY9DEw0la2ftajzVrZR9EilnFpRasCLlhWHYLwisvTWIu/?= =?us-ascii?Q?lDEbSYDI2ZcQ5MEUObV3Ib8BmM8ueojnBeLWEYPlYR7n/srPwClDAe/8Sx1s?= =?us-ascii?Q?rz7WvFAMh04mBK5RKySOYXHS8ZRTWg2WbgENr9Mju7Jnd+la449hgIrC4jj9?= =?us-ascii?Q?03GoFkiQvryqMx3ZY4q2gCu+4pE7HiETxt82wpFe51oA2kiz8DO1j5dIha4e?= =?us-ascii?Q?7RT3gyYE3omD2GRS0qYUy3zcnlWXGMuED1MEYii5g+nobR+iMnMhVgyqv5RF?= =?us-ascii?Q?31pT4w50zcVbkVvLzhS43N33YuKGHR78sfETqZSkHzCMhWupTYf5+FI3MYl2?= =?us-ascii?Q?DudM5W2mUyB/GEzX1j3kafui+UET401nzCbJehLpb6gwv37UyWiEjHN7BVA8?= =?us-ascii?Q?GLuIxgTTpy+2366Vc6uCUtgDEizthotbPFeSLzokQFh6zg4bGoXD7kgFXc9q?= =?us-ascii?Q?cFESxDRAqUGRKKH8vpKiSWsB7CbpQ+QY1zG7pr3zVTl/I7kh7w7x2eN88ViA?= =?us-ascii?Q?JBZcs+Z72G9KRwkVBaq03XEter9SBslpbApeb5QeV2kBSK+gx8T8/xlxz0wq?= =?us-ascii?Q?SGhxxFOhJAgndsPISPFvQLsMIia23UnRcE0NDh7ewEsd96W0T09ptI0nmpIm?= =?us-ascii?Q?Z9fpkIYsw4izv/wHHqrE1j6/AZL0R1tFjjn5xuHwZcDgNQw5TQ1JyQYYJSHA?= =?us-ascii?Q?y/GUXCETDIMSPiKQNLR/ph5yNEDgC99tD/JGdFBPZRpJ9PG/evvDDVMajScW?= =?us-ascii?Q?W88cRL6MjMDVazW5tpWYcKNOmSc1C1/VHDfWr5copkRrnDIX7Tj/WSCMNycp?= =?us-ascii?Q?vqwdi4obfbw9wtXU2Vtjw0RhI5diYkSvslzYi3BAZE+9RssphjYB7UDOlvSV?= =?us-ascii?Q?BeC34bBOiuUibq2HW3z3exSVvaeAfYL+licvHtV2fY4NrmVSP5Kh94oi35j7?= =?us-ascii?Q?JMpTkwiKQxIhydBlPrV18+AcHqjEpzIE8OygnaFoCQh0VIxBEd06aValdG7L?= =?us-ascii?Q?URPX2QNdGstICDVnDhIG9p4JZt7tGSIxnnpRsKv8pS+/xmp4qMOmBpuwPYUv?= =?us-ascii?Q?PYQvGG4+W6/XOjFkCpQh0hDlvMJX1vy2Aelefw1/SXJ9iYCybhznRpJp8at0?= =?us-ascii?Q?4psTAR06pdTHm8knnPkYdLP6QocN74pcNp0+yP74dkShd9pKxOhDtK19gAAK?= =?us-ascii?Q?s/CLjmXcgXuh2Rm3viRJRyXqLFBVb3YnZrzX10ax822d5adMiM6Zk6VTPTKi?= =?us-ascii?Q?3cgJKqNiR8rXPmwm5KQ5ldA29rSclIqG7O0dWsAdKT0as8N/5cIJ7DDMh3iR?= =?us-ascii?Q?Wg4YJ0kdi/iamPO7SpFy8gvMteaNrl+cpCITcEj1/MfdRPrwI8G6zMbKChYr?= =?us-ascii?Q?OjLrWmifjsEHBw91LstvOxv727vrSPnWKYJ0hWvGbKaySPwRowRrS9AGdwNN?= =?us-ascii?Q?WwSx3/XVa0lkgz19yUlLhrdYHayMlqJIUjD4Or3AdRblPnBRtZuK3ptKcaQ2?= =?us-ascii?Q?bWY=3D?= __substg1.0_0C190102*Nv__substg1.0_0C1A001F*8:P*__substg1.0_0C1D0102*Q__substg1.0_0C1E001F*9=Ramendments@hra.nhs.ukSMTP:NOREPLY@HARP.ORG.UKSMTPnoreply@harp.org.ukSIS, ResourceWILSON, Mark (IMPERIAL COLLEGE HEALTHCARE NHS TRUST); k.boland@imperial.ac.uk__substg1.0_0C1F001F*S&__substg1.0_0E02001F*<>__substg1.0_0E03001F*T__substg1.0_0E04001F*/_U__substg1.0_0E05001F*X __substg1.0_0E0B0102*@BY.__substg1.0_0E1D001F*Z~__substg1.0_0E4C0102*AE\Inboxf͛/Z {.qhLƳA?"1IRAS Project ID 316755. HRA and HCRW Approval for the AmendmentRMj7q8Q[@5k,/-JeP d126FCE069AE970438340CE96BDA0FED4__substg1.0_0E590102*]__substg1.0_0F030102*DF^__substg1.0_1000001F*H__substg1.0_10090102*CKTYou don't often get email from noreply@harp.org.uk. Learn why this is important<https://aka.ms/LearnAboutSenderIdentification> Dear Prof Wilson, IRAS Project ID: 316755 Short Study Title: Spinal Immobilisation Study (SIS) Amendment No./Sponsor Ref: NSA 11 Amendment Date: 07 April 2025 Amendment Type: Non Substantial Non-CTIMP I am pleased to confirm HRA and HCRW Approval for the above referenced amendment. You should implement this amendment at NHS organisations in England and Wales, in line with the guidance in the amendment tool. User Feedback The Health Research Authority is continually striving to provide a high quality service to all applicants and sponsors. You are invited to give your view of the service you have received and the application procedure. If you wish to make your views known please use the feedback form available on the HRA website: http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/<https://eur01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.hra.nhs.uk%2Fabout-the-hra%2Fgovernance%2Fquality-assurance%2F&data=05%7C02%7Csis%40warwick.ac.uk%7C5afeb06e035a4259109c08dd75e56ade%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638796350377235194%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=xfD%2B%2F4sWWOBEuQEsjFsyA1fuuqpU12atN1M8Avg83r0%3D&reserved=0>. Please contact amendments@hra.nhs.uk<https://eur01.safelinks.protection.outlook.com/?url=http%3A%2F%2Famendments%40hra.nhs.uk%2F&data=05%7C02%7Csis%40warwick.ac.uk%7C5afeb06e035a4259109c08dd75e56ade%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638796350377254739%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=jSZ%2BRO2AoVPgf%2F6Jsz5qwOMVyzCfDn5wSBoRvmMrkxQ%3D&reserved=0> for any queries relating to the assessment of this amendment. Kind regards Ashley Totenhofer Health Research Authority 2nd Floor | 2 Redman Place | Stratford | London | E20 1JQ E.amendments@hra.nhs.uk<mailto:amendments@hra.nhs.uk> W. www.hra.nhs.uk<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.hra.nhs.uk%2F&data=05%7C02%7Csis%40warwick.ac.uk%7C5afeb06e035a4259109c08dd75e56ade%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638796350377269468%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=v%2BZ6WKe805hVXD7B%2FhB8c2uYRlpILlqxQur94TQ%2F6o0%3D&reserved=0> Sign up to receive our newsletter HRA Latest<https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.hra.nhs.uk%2Fabout-us%2Fhra-latest%2F&data=05%7C02%7Csis%40warwick.ac.uk%7C5afeb06e035a4259109c08dd75e56ade%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638796350377284859%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=xWf4qA1nCy%2FiptGLAGkXCvVWcF7TtHuNPKaQBA0S21k%3D&reserved=0> YfLZFu:|Fa fbidccpg1252Rhtml1 ch set0 mP2ý2 3 wf_pgoe-ui_nq} ; b19 b 2a663234  2 5ʬ84 33 94w`C* aNtP`so Ex1n#pRvW"tPn%qtM &d R "\vwk d5(@`0 r!#2bkmks BM_BEGIN}*&#Pqg64,<>.Pead.(tp-eq8v="&&0-Type"'0b0&8xt/('D=WU(o)p-".tit)>SE56 (App`v@)0'94PTem Q& 5 p #'fi HRA 4'a)8atD 2?$0EN-G>B0 3:btr?3Ab  0B00ells c @C d Cdth0)%0:58C0#io;P p& !pp p=Bk `)G_Hc H=UIoHBK?LD@pLHbNO=P05K/O0T( ::@ROOp$`P/HS pFG0nVoWtC `THS=Z/20:\]0.]Hb)@=PC__`c:as20rg cHboCTf%Lfu3:hfC%qf wj_HbDl/m3$P3XH5 p[pN@5qoHb)sHb[uz)-Yivu1-@;oy(0qzy0Gz}ky>s@3yAq&"yw#p/ufuÄooHupQCPFHb&P@z/)T/Gwh3pCvERB-b pak?Ga:3%-b?HbzoNODX;PKhCIYB4/=Ewx6x'Q `pp;Pp0##;P#O`;GFqb:q3-}P9FHIJϪOMPVOQ/SO?Uo/WYZ\ş^`b/ƯdOfogiOln׏qrt?uOڟxy{}?/oO߈oߘ/Ooϛol# ߵ߶O/?OoŸĿ!?"/?O_(ҏӟԯ-3_/6O8o@//?O_o2=*?S/?$_o00vUmd7 WCͭ1@ bgCx#A6cB Н)7A2Ad  f iln/?OroMx&!}o$&/'?(O)_+,-.01w367/9O;oIQ>?@AϜODFGH/I?JOK_LoNOPRφoT/WZY/Z?\_]o^ύdgoht-ouc57ad0?/TD@pf \ @`d\wP`0h0h0 @ftsW2ƁwC50@X\clRcqc:b tȐɀl84ʤ@3ʤr2&jr˵bb˵ʀ4aDt˱cxopw˵6Ϣ̏͜18҆&8856ϸΓЏџү~&1Ա8\ s@ϰUc0`m`a@%bEA2cud5d1b21"efhiklOoq?rOs_uvxz{}O?O_o 奔o/?_ϝ/?#_oϮ?4_o:3f2oM4 ?-faEa`l0wf_+goui_n$, SD UIDDWPDTah;@aDA9 Ds)+9 fB/0BqwDO$%?- 6?&E5c&@_ 0v=U;_/[oO_o^)dj//kOn/oq v do|O?Oo%/x"/#?$O%_&o'()*+,φ.s/13/O5O6_m89:āܓa0f!݈\pİf0f0!02057Ps1s Yd'MT ok gm ^p KpK"ef Dy@rp.^g.uk. ļaiM}`f otpk//`a.ms/LPrnAXvPErIGaUT+\O(`TdfgT:rTXTgTvT+ސ}ld޲zRp HYPERLINKQorgbp cfum S1yPs Tf޼/AǻӐ/DR@Ǹ0޻qTDǸݼ޿N7SAW_oSOT_/VXZ[]OOb/c?e_OgOojlϤnqrt?Ov_woOy {| ~o/φOo? o$O?O_o_/ߡ1/?7_0޲>?@A&COD_EoFGHEOJOLMNPQKQٻw,ڟRRwϪSedyPǰl ֠`cW!H~gCнrn E0ob\Wpes,tH >0>`aF>@CF@taطWolcdelg?{?iUYWmnZU3'`Fe@ck]Y}oy|loTaHW`6v'`J`cvAu>`?ЫrW@nuMplYQiv0g?W]R>@a%& q1b1wWAW]@cCr\sٔscqBJ`w'WvgayqPezwsfaƖ%ab3F@udaÓĽC]QbіecIpR>0cqWmakrknOWS F!abarW Rsw\bweC&@ba#attps://e01. bHk]Q 'Q.qPxk.WHm/?l=%3A%2FqwB.`a.nhukqb-a-qgb!r`bqEZ-PsE&&=q%7CPqsp%40wJ`>0.5b06e03P.P59109c08dd75e/ar9fb-@7.@60>2`P W`f6 bcr638790>3772194qUbqTWFpbGZ3d8eyJFbXB0eU1hcGkiOnRyd"W IlYiIwLjMDAw(MCIQAJX`aW4zMPkFOIjoi#sDdUyfQ@D'B&sxf `2Bq4sWWOBEuQEsjFsyA1fuuqpp2N1M8Avg83`A&b`A0(Apy0ls/է///(hY qfq0#\PYPERLINK ߥ/?O_o߶/?O_e_q(6 ِ,Vq1X{܃AK`VI.5_ HIK׈_h?kOV Pď҃o_oё2/8P739/?O_oC=jSZRO2AoVPgfA6Jsz5qw@OMVyzCn5wSBoRvmMrkx ؞@I(ptet'_RCk?O _ o  /?O_o/\"Bx`\@b&rb`auss3cry/z?|_Oo?Q_RoHo[KXb`tWro|VoN_V~Wv@y$p*r@tb(0vf115`5);Ĺe#0hfffWX^ CZAqT)Q `Jdbc?\Y]_/`?pef84f@10P)$HMC5sqr^t_}2[aF*|f{Mdp/@Ѕ }P1Lm~ d EZx@JQxrtuv߿f1x1xkJ6zoE]}~PK:E?B$%&_jB?kOD_OFGoj߂? J ,0gizee11pt;яh㐏QzW?Md٪Iyno//(/)?*M./,-/0?1/2?3O4_685678:; SE56 (Approval) Template email to confirm HRA Approval for an amendment

ý

You don't often get email from noreply@harp.org.uk.

Dear Prof Wilson,

IRAS Project ID:
316755
Short ý Title:
Spinal Immobilisation ý (SIS)
Amendment No./Sponsor Ref:
NSA 11
Amendment Date:
07 April 2025
Amendment Type:
Non Substantial Non-CTIMP

I am pleased to confirm HRA and HCRW Approval for the above referenced amendment.    

You should implement this amendment at NHS organisations in England and Wales, in line with the guidance in the amendment tool.

User Feedback

The Health Research Authority is continually striving to provide a high quality service to all applicants and sponsors. You are invited to give your view of the service you have received and the application procedure. If you wish to make your views known please use the feedback form available on the HRA website: .

Please contact for any queries relating to the assessment of this amendment.

Kind regards

Ashley Totenhofer
Health Research Authority
2nd Floor | 2 Redman Place | Stratford  | London | E20 1JQ
E.amendments@hra.nhs.uk
W.

Sign up to receive our newsletter


@eurprd01.prod.exchangelabs.com<a1867882-2b05-4a13-8761-51bdad89cf93@DU6PEPF0000B61F.eurprd02.prod.outlook.com>#ɢOs>n6/-JeP d k__substg1.0_300B0102*e__substg1.0_30130102*LNf__substg1.0_30140102*g __substg1.0_36770102*GWhQ  KQW +13579;=GISUY]'-?"B?@@??*%)ACE2/:B[amendments@hra.nhs.uk+nTamendments@hra.nhs.ukSMTPnoreply@harp.org.ukSIS, Resourceܧ@B+//O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C__substg1.0_3FF8001F*j*__substg1.0_3FF90102*PRkv__substg1.0_3FFA001F*m__substg1.0_3FFB0102*QUn875F5632DDE22D7C-SISSMTPnoreply@harp.org.ukEX/O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=DA0F5B4CA90F495C875F5632DDE22D7C-SIS__substg1.0_4022001F*q__substg1.0_4023001F*TVr&__substg1.0_4024001F*s__substg1.0_4025001F*S[t__substg1.0_4030001F*x*__substg1.0_4031001F*XZy*__substg1.0_4034001F*zH__substg1.0_4035001F*Y]|Hamendments@hra.nhs.ukamendments@hra.nhs.ukDA0F5B4CA90F495C875F5632DDE22D7C-SISDA0F5B4CA90F495C875F5632DDE22D7C-SISamendments@hra.nhs.ukSIS, Resource__substg1.0_4038001F*~*__substg1.0_4039001F*\^__substg1.0_50CF0102*__substg1.0_5D01001F*Oo&7prVUbmt5kq2Yf1DaAJ3tg==noreply@harp.org.uknoreply@harp.org.ukSIS@warwick.ac.ukSIS@warwick.ac.uknoreply@harp.org.ukSIS@warwick.ac.ukϺ GeDe5F__substg1.0_5D02001F*&__substg1.0_5D07001F*`b"__substg1.0_5D08001F*"__substg1.0_5D0A001F*ae&__substg1.0_5D0B001F*"__substg1.0_5D160102*df__substg1.0_65E00102*__substg1.0_65E10102*ck{.qhLƳA?"0{.qhLƳA?" {.qhLƳA?"k{.qhLƳA?"kHl+XlDX{p >wy50Kx* eyJJc1VybEJlaW5nU2Nhbm5lZCI6IiIs__substg1.0_65E20102*__substg1.0_65E30102*hj__substg1.0_70970102* __substg1.0_80000048*im__substg1.0_80060102*"__substg1.0_8007001F*lnX__substg1.0_80090048*__substg1.0_800D001F*gIlVybFdyaXRlVGltZSI6IjQvNy8yMDI1IDM6MDM6NTcgUE0iLCJBU0RpcmVjdGlvbmFsaXR5IjoiMSIsIlBoaXNoRWR1IjoiMCIsIk1zZ1NjYW5TdXNwaWNpb25MZXZlbCI6IjAifQ==nZZYBujenBT=0;II=<invalid>;TFR=ThreadFork__substg1.0_800E001F*__substg1.0_80120102*pr __substg1.0_80130102* __substg1.0_8014001F*quzingIsDisabled;Version=Version 15.20 (Build 8583.0), Stage=H12;UP=10;DP=1;QT=9;CPBT=FocusedInboxFeatureSet_50104B??? ? ??@@ !"#$%&'(?)*+?,-./1A2345678BEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~?? D@@AdCG=)\={n?G?= W>= W>@BG@= > ף<\B>= W>z>? ף<\B> ף=(\?33s?DB>33?u> ף<q=> R> >  ף<  q=>R>{n? !k?"#$%?&WC'@(@@)?*+, ף=- #<./L?0<12G=3H:?456789:;<=>=?L?@)\>AH:?BCDEF\B>GL>H ף?I?JK)\@Lfff?MNף?O @PQRSTUVWXYZ?[)\@\R?] @^_`ab{?cף?de@fg?FocusedInboxFeatureSet_50104B??? ? ??@@ !"#$%&'(?)*+?,-./1A2345678BEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~?? D@@AdCG=)\={n?G?= W>= W>@BG@= > ף<\B>= W>z>? ף<\B> ף=(\?33s?DB>33?u> ף<q=> R> >  ף<  q=>R>{n? !k?"#$%?&WC'@(@@)?*+, ף=- #<./L?0<12G=3H:?456789:;<=>=?L?@)\>AH:?BCDEF\B>GL>H ף?I?JK)\@Lfff?MNף?O @PQRSTUVWXYZ?[)\@\R?] @^_`ab{?cף?de@fg?ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(4710137)(4713057)(470014026)(4714077)(4999040)(920097)(930097)(140003)(1420198);[{"url":"https://aka.ms/LearnAboutSenderIdentification","url/anchorText":"Learn why this is important","url/urlTextSpan":{"beginIndex":9709,"length":27},"@EntityId":"69c2f3bc-7798-496e-90ce-536e687793b6","@extractionTimeUtc":"2025-04-07T15:04:00.0838006\u002B00:00"},{"url":"https://eur01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.hra.nhs.uk%2Fabout-the-hra%2Fgovernance%2Fquality-assurance%2F\u0026amp;data=05%7C02%7Csis%40warwick.ac.uk%7C5afeb06e035a4259109c08dd75e56ade%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638796350377235194%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C\u0026amp;sdata=xfD%2B%2F4sWWOBEuQEsjFsyA1fuuqpU12atN1M8Avg83r0%3D\u0026amp;reserved=0","url/anchorText":"http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/","url/urlTextSpan":{"beginIndex":14087,"length":65},"@EntityId":"3ac138dd-a753-437b-a44f-f503afb760c3","@extractionTimeUtc":"2025-04-07T15:04:00.0838093\u002B00:00"},{"url":"https://eur01.safelinks.protection.outlook.com/?url=http%3A%2F%2Famendments%40hra.nhs.uk%2F\u0026amp;data=05%7C02%7Csis%40warwick.ac.uk%7C5afeb06e035a4259109c08dd75e56ade%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638796350377254739%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C\u0026amp;sdata=jSZ%2BRO2AoVPgf%2F6Jsz5qwOMVyzCfDn5wSBoRvmMrkxQ%3D\u0026amp;reserved=0","url/anchorText":"amendments@hra.nhs.uk","url/urlTextSpan":{"beginIndex":14846,"length":21},"@EntityId":"3bad416f-42c6-4b14-bbee-5bfa59b8e051","@extractionTimeUtc":"2025-04-07T15:04:00.0838128\u002B00:00"},{"url":"https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.hra.nhs.uk%2F\u0026amp;data=05%7C02%7Csis%40warwick.ac.uk%7C5afeb06e035a4259109c08dd75e56ade%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638796350377269468%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C\u0026amp;sdata=v%2BZ6WKe805hVXD7B%2FhB8c2uYRlpILlqxQur94TQ%2F6o0%3D\u0026amp;reserved=0","url/anchorText":"www.hra.nhs.uk","url/urlTextSpan":{"beginIndex":15963,"length":14},"@EntityId":"bbb59ad7-09c8-4d1e-bb1b-ade0097947f4","@extractionTimeUtc":"2025-04-07T15:04:00.0838174\u002B00:00"},{"url":"https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.hra.nhs.uk%2Fabout-us%2Fhra-latest%2F\u0026amp;data=05%7C02%7Csis%40warwick.ac.uk%7C5afeb06e035a4259109c08dd75e56ade%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638796350377284859%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C\u0026amp;sdata=xWf4qA1nCy%2FiptGLAGkXCvVWcF7TtHuNPKaQBA0S21k%3D\u0026amp;reserved=0","url/anchorText":"HRA Latest","url/urlTextSpan":{"beginIndex":16583,"length":10},"@EntityId":"10bd6943-b5ea-42f1-9574-f4a0e7fc587e","@extractionTimeUtc":"2025-04-07T15:04:00.0838209\u002B00:00"}]__substg1.0_8015001F*__substg1.0_801A001F*tv__substg1.0_801B001F*__substg1.0_801C0048*s{[{"url":"https://aka.ms/LearnAboutSenderIdentification","url/urlTextSpan":{"beginIndex":9709,"length":27},"@EntityId":"69c2f3bc-7798-496e-90ce-536e687793b6","@extractionTimeUtc":"2025-04-07T15:04:00.0838006\u002B00:00"},{"url":"https://eur01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.hra.nhs.uk%2Fabout-the-hra%2Fgovernance%2Fquality-assurance%2F\u0026amp;data=05%7C02%7Csis%40warwick.ac.uk%7C5afeb06e035a4259109c08dd75e56ade%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638796350377235194%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C\u0026amp;sdata=xfD%2B%2F4sWWOBEuQEsjFsyA1fuuqpU12atN1M8Avg83r0%3D\u0026amp;reserved=0","url/urlTextSpan":{"beginIndex":14087,"length":65},"@EntityId":"3ac138dd-a753-437b-a44f-f503afb760c3","@extractionTimeUtc":"2025-04-07T15:04:00.0838093\u002B00:00"},{"url":"https://eur01.safelinks.protection.outlook.com/?url=http%3A%2F%2Famendments%40hra.nhs.uk%2F\u0026amp;data=05%7C02%7Csis%40warwick.ac.uk%7C5afeb06e035a4259109c08dd75e56ade%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638796350377254739%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C\u0026amp;sdata=jSZ%2BRO2AoVPgf%2F6Jsz5qwOMVyzCfDn5wSBoRvmMrkxQ%3D\u0026amp;reserved=0","url/urlTextSpan":{"beginIndex":14846,"length":21},"@EntityId":"3bad416f-42c6-4b14-bbee-5bfa59b8e051","@extractionTimeUtc":"2025-04-07T15:04:00.0838128\u002B00:00"},{"url":"https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.hra.nhs.uk%2F\u0026amp;data=05%7C02%7Csis%40warwick.ac.uk%7C5afeb06e035a4259109c08dd75e56ade%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638796350377269468%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C\u0026amp;sdata=v%2BZ6WKe805hVXD7B%2FhB8c2uYRlpILlqxQur94TQ%2F6o0%3D\u0026amp;reserved=0","url/urlTextSpan":{"beginIndex":15963,"length":14},"@EntityId":"bbb59ad7-09c8-4d1e-bb1b-ade0097947f4","@extractionTimeUtc":"2025-04-07T15:04:00.0838174\u002B00:00"},{"url":"https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.hra.nhs.uk%2Fabout-us%2Fhra-latest%2F\u0026amp;data=05%7C02%7Csis%40warwick.ac.uk%7C5afeb06e035a4259109c08dd75e56ade%7C09bacfbd47ef446592653546f2eaf6bc%7C0%7C0%7C638796350377284859%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C\u0026amp;sdata=xWf4qA1nCy%2FiptGLAGkXCvVWcF7TtHuNPKaQBA0S21k%3D\u0026amp;reserved=0","url/urlTextSpan":{"beginIndex":16583,"length":10},"@EntityId":"10bd6943-b5ea-42f1-9574-f4a0e7fc587e","@extractionTimeUtc":"2025-04-07T15:04:00.0838209\u002B00:00"}]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iGMDU6PEPF0000B61F.eurprd02.prod.outlook.comAnonymous5.101.140.16310.167.8.134Email)L __substg1.0_801F001F*R__substg1.0_8020001F*xz__substg1.0_8021001F*__substg1.0_8022001F*y}__substg1.0_8023001F* __substg1.0_80250102*|~__substg1.0_8027001F*d__substg1.0_8028001F*w>     !"#$%&')*+,-/369;<?DIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~[ { "@type": "ExtractLanguage", "@context": "http://schema.microsoft.com", "@outputVersion": "1.0", "@source": "Bling", "BlingDetectorType": "ExternalWithHints", "TextLength": 1203, "LanguageScores": { "English": 100.0 }, "Language": { "Locale": "en-US", "name": "English (United States)", "BestGuessLanguage": "en", "@type": "Language" } } ]FocusedSenderByRatioBCAT=BulkDueToWellKnownSenderLoc[ { "@outputVersion": "2.0", "@formatter": "TeeKpeBondCbpBase64", "@schema": "Microsoft.Exchange.Relevance.TeeKpeBondResponse.TeeKpe.TeeKpeResponse", "@correlationTrail": "AssetId=0525a699-e21a-4f7b-8536-00e602cb62f2;ExtractionId=b59ed7c8-c0ae-4f0f-80e7-3a894ea0a525;EntityId=c70e1855-1d49-489b-9722-bdd6e27b6f3d", "keyPhrases": "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", "@type": "KeyPhraseExtraction", "@context": "http://schema.microsoft.com", "@EntityId": "c70e1855-1d49-489b-9722-bdd6e27b6f3d", "@extractionTimeUtc": "2025-04-07T15:04:00.1224141Z" } ]__substg1.0_8029001F*(__substg1.0_802A001F*@__substg1.0_802B001F*__substg1.0_802C001F*ralPatterns;DNRT=Microsoft.Exchange.FocusedInbox.Models.Heuristics.DoNotReplyFeaturizer+DoNotReplyTypes;SCAT=None;RFV=1032232302:-1=8^-1927059262:-1=1^1146315108:-1=0^1810071250:sender-53ff53cf-00c5-496c-9c82-24cd4c9acbb2=0^1352796317:recipient-5f4eeba7-051b-48b8-a034-49d0e50da419=1537^1352796317:recipient-68c0a269-38e0-4256-9014-275e3c63320d=1025^1352796317:recipient-ead3abdd-95fa-410a-bfb4-a952f197f93b=2689^;SV=1.0.669.0;SN=DB9PR01MB8191;MV=5010;CT=4/7/2025 3:03:57 PM;ODF=Inbox;IFIC=<null>;HDTR=0;HDTF=V1540.6845815Pass (protection.outlook.com: domain of harp.org.uk designates 5.101.140.163 as permitted sender) receiver=protection.outlook.com; client-ip=5.101.140.163; helo=cpanel.harp.org.uk; pr=C--DEPRECATED--__substg1.0_802D001F*__substg1.0_802E001F*__substg1.0_802F001F* __substg1.0_8030001F*(|CIP:5.101.140.163;CTRY:GB;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:cpanel.harp.org.uk;PTR:cpanel.harp.org.uk;CAT:NONE;SFTY:9.25;SFS:(13230040)(3072899012)(12012899012)(2092899012)(8096899003)(13003099007)(43540500003);DIR:INB;SFTY:9.25;spf=pass (sender IP is 5.101.140.163) smtp.mailfrom=harp.org.uk; dkim=none (message not signed) header.d=none;dmarc=bestguesspass action=none header.from=harp.org.uk;compauth=pass reason=109DU6PEPF0000B61F:EE_|DU0PR01MB9358:EE_|DB7PR01MB4396:EE___substg1.0_8031001F*.n__substg1.0_8032001F*0>__substg1.0_8033001F*1__substg1.0_8034001F*2H07 Apr 2025 15:03:55.6595 (UTC)Internet09bacfbd-47ef-4465-9265-3546f2eaf6bcDU0PR01MB93585afeb06e-035a-4259-109c-08dd75e56ade00:00:01.9298160__substg1.0_8035001F*4__substg1.0_8036001F*5H__substg1.0_8037001F*7 __substg1.0_8038001F*8H5afeb06e-035a-4259-109c-08dd75e56adeBCL:2;ARA:13230040|3072899012|12012899012|2092899012|8096899003|13003099007|43540500003;15.20.8583.043DU6PEPF0000B61F.eurprd02.prod.outlook.com__substg1.0_8039001F*:__substg1.0_803A001F*=__substg1.0_803B001F*>R__substg1.0_803C001F*@AnonymousSA|SL009bacfbd-47ef-4465-9265-3546f2eaf6bc:01;en1;True__substg1.0_803E001F*A __substg1.0_803F001F*B__substg1.0_8040001F*CL__substg1.0_8042001F*E__substg1.0_8043001F*F__substg1.0_8045001F*G__substg1.0_8047001F*H__substg1.0_8049001F*6     0=100;1=0;2=0;3=1;4=0;5=1;6=0;7=0;8=1;9=0;10=0;11=1;12=0;13=0;14=0;15=0;16=0;17=0;18=0;20=1;25=1;27=0;28=3;29=0;30=0;31=0;32=0;33=0;34=0;35=0;36=0;37=0;38=0;39=0;40=1;41=0;42=0;43=1;44=0;45=0;46=0;47=0;49=8;50=0;51=0;52=0;53=0;54=0;55=0;56=0;66=0;69=0;70=0;71=0;72=0;73=0;74=0;75=0;76=0;77=0;78=0;79=0;80=0;81=0;82=0;83=0;84=0;85=0;86=0;87=0;88=0;89=0;90=0;91=0;92=0;93=0;94=0;95=0;96=0;97=0;98=0;99=0;100=0;101=0;102=0;103=0;104=0;105=0;106=0;107=0;108=0;109=0;110=0;111=0;112=0;113=0;114=0;115=0;116=0;117=0;118=0;119=0;120=0;121=0;122=0;123=0;124=0;125=0;126=0;127=0;128=0;129=0;130=0;131=0;132=0;133=0;134=0;135=0;136=0;137=0;138=0;139=0;140=0;141=0;142=0;143=0;144=0;145=0;146=0;147=0;148=0;149=0;150=0;151=0;152=0;153=0;154=0;155=0;156=0;157=0;158=0;193=1;194=1;195=2025;196=3;197=8;198=0;199=0;200=0;201=228;202=0.11;203=0.07;204=0;205=0.93;206=0;207=0.78;208=0;209=0;210=0.21;211=0.21;212=48;213=0;214=0;215=2.27;216=0;217=0.42;218=0.02;219=0;220=0;221=0;222=0;223=0;224=0.19;225=0.21;226=0.29;227=0.5;228=0;229=0;230=0;231=0.02;232=0.19;233=0;234=0;235=0;236=0;237=0;238=0;239=0;240=0;241=0;242=0;243=0;244=0;245=0;246=0.08;247=0.86;248=0;249=0.95;250=0;251=0;252=49;253=0.15;254=0;255=1.9;256=0;257=0.24;258=0.02;259=0;260=0;261=0;262=0;263=0;264=0.27;265=0.31;266=0.39;267=0.02;268=0;269=0;270=0;271=0;272=0.27;273=0;274=0;275=0;276=0;277=0;278=0.31;279=0;280=0;281=0;282=0;283=0;284=0;285=0;286=0;287=0.93;288=0;289=0.92;290=0;291=0;292=0;293=1;294=215;295=2.33;296=3;297=0.6;298=0;299=0;300=0.08;301=0.01;302=0;303=0.8;304=0.03;305=0;306=0.11;307=0.73;308=0;309=0;310=0;311=0;312=0;313=0;314=0;315=0;316=0;317=0;318=0.1;319=0.8;320=0.14;321=0.73;322=0;323=0;324=0;325=0;326=0.19;327=0.2;328=1.28;329=0.6;330=0;331=2.24;332=0.9;333=0;334=1.38;335=2.2;336=0;337=0;338=0;339=0;340=0;341=0;342=0;343=0;344=0;345=0;346=1.34;347=2.24;348=1.49;349=2.2;350=0;351=0;352=0;353=0;354=1.61;355=1.63;356=0;357=2;358=0;359=1Christina.May@warwick.ac.uk00000002/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIB__substg1.0_804A001F* __properties_version1.00 __recip_version1.0_#00000000:@QϧgQϧ__substg1.0_0C240102*OHF23SPDLT)/cn=Recipients/cn=bb1efab5980d40e1865a13871d4a85c0-u2173714@0@ ϧ@0@ ϧ 4y .:seN:sH U6?67= E6@IΧep 0q)**+,-./01234567"89:;< => ?@N AB CDE  FG HC'`s M@sI8J8Q[@5k,wojOtUhܧ@B+//o=ExchangeLabs/ou=Exchange Administ__substg1.0_0C2C0102*__substg1.0_0FF60102*__substg1.0_0FF90102*}__substg1.0_0FFF0102*}rative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=user7137448cܧ@B+//o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=user7137448cWILSON, Mark (IMPERIAL COLLEGE HEALTHCARE NHS TRUST)EX/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDL__substg1.0_3001001F*h__substg1.0_3002001F*__substg1.0_3003001F*__substg1.0_39FE001F**T)/cn=Recipients/cn=user7137448cmark.wilson19@nhs.netWILSON, Mark (IMPERIAL COLLEGE HEALTHCARE NHS TRUST) ܧ@B+//o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=user7137448c/o=ExchangeLabs/ou=Exchange Admi__substg1.0_3A20001F*h__substg1.0_5FE5001F*__substg1.0_5FF70102*}__substg1.0_66CA001F*nistrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=user7137448c0j00n }QCc :j  @:}HCc_}`^Cc9$ Qk, вo9@9,__f0__properties_version1.00X__recip_version1.0_#00000001:gQϧgQϧ__substg1.0_0FF60102*__substg1.0_0FF90102*+nTk.boland@imperial.ac.ukSMTPk.boland@imperial.ac.uk+nTk.boland@imperial.ac.ukSMTPk.boland@imperial.ac.ukk.boland@imperial.ac.uk__substg1.0_0FFF0102*__substg1.0_3001001F*.__substg1.0_3002001F*__substg1.0_3003001F*.SMTPk.boland@imperial.ac.ukk.boland@imperial.ac.ukk.boland@imperial.ac.uk+nTk.boland@imperial.ac.ukSMTPk.boland@imperial.ac.uk000 00__substg1.0_39FE001F*.__substg1.0_3A20001F*.__substg1.0_5FF70102*__properties_version1.00{n FCc :0  @:_s_H`s990_08Q[@5k,)#9DԍWQFܧ@B+//o=ExchangeLabs/ou=Exchange Administ__recip_version1.0_#00000002:gQϧЎQϧ__substg1.0_0C240102*__substg1.0_0C2C0102*__substg1.0_0FF60102*__substg1.0_0FF90102*__substg1.0_0FFF0102*__substg1.0_3001001F*__substg1.0_3002001F*rative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=da0f5b4ca90f495c875f5632dde22d7c-sisܧ@B+//o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=da0f5b4ca90f495c875f5632dde22d7c-sisSIS, ResourceEX/o=ExchangeLabs/ou=Exchange Admi__substg1.0_3003001F*__substg1.0_39FE001F*"__substg1.0_3A20001F*__substg1.0_5FE5001F*4nistrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=da0f5b4ca90f495c875f5632dde22d7c-sisSIS@warwick.ac.ukSIS, Resourcesip:sis@live.warwick.ac.ukܧ@B+//o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=da0f5b4ca90f495c__substg1.0_5FF70102*__substg1.0_66CA001F*__properties_version1.00X  875f5632dde22d7c-sis/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=da0f5b4ca90f495c875f5632dde22d7c-sis000|n ss :  @:ss_@ss9$ Ѓk, o9@9$_6_f0